Pre-order Enquiry
Download Free Sample
Healthcare
Aerospace & Defence
Agriculture
Automations
Chemicals & Advanced Materials
Food & Beverages
Information & Communication Technology
Oil & Gas
Power & Energy
Epirubicin Hydrochloride is the hydrochloride salt of the 4'-epi-isomer of the anthracycline antineoplastic antibiotic doxorubicin. Epirubicin intercalates into DNA and inhibits topoisomerase II, thereby inhibiting DNA replication and ultimately, interfering with RNA and protein synthesis. This agent also produces toxic free-radical intermediates and interacts with cell membrane lipids causing lipid peroxidation.
According to our Researcher latest study, the global Epirubicin Hydrochloride market size was valued at USD 260.5 million in 2022 and is forecast to a readjusted size of USD 219.9 million by 2029 with a CAGR of -2.4% during review period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
Global core Epirubicin Hydrochloride players include Synbias Pharma, Zhejiang Hisun Pharma and Pfizer etc. The top 3 companies hold a share about 60%. Asia-Pacific is the largest market, with a share about 45%, followed by Europe and North America with the share about 25% and 20%.
In terms of product, 10mg/5ml is the largest segment, with a share about 45%, followed by 50mg/25ml, with a share about 40%. And in terms of application, the largest application is cancer, with a share about 95%, followed by others, with a share about 5%.
This report is a detailed and comprehensive analysis for global Epirubicin Hydrochloride market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.
Key Features:
Global Epirubicin Hydrochloride market size and forecasts, in consumption value ($ Million), sales quantity (Kg), and average selling prices (US$/Kg), 2018-2029
Global Epirubicin Hydrochloride market size and forecasts by region and country, in consumption value ($ Million), sales quantity (Kg), and average selling prices (US$/Kg), 2018-2029
Global Epirubicin Hydrochloride market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (Kg), and average selling prices (US$/Kg), 2018-2029
Global Epirubicin Hydrochloride market shares of main players, shipments in revenue ($ Million), sales quantity (Kg), and ASP (US$/Kg), 2018-2023
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Epirubicin Hydrochloride
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Epirubicin Hydrochloride market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Sterling Biotech, Zhejiang Hisun Pharma, Flavine, Teva API and Microbiopharm Japan, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Market Segmentation
Epirubicin Hydrochloride market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
10mg/5ml
50mg/25ml
Other
Market segment by Application
Cancer
Others
Sterling Biotech
Zhejiang Hisun Pharma
Flavine
Teva API
Microbiopharm Japan
DZD Heze Pharma
Synbias Pharma
Intas Pharma
Humble Healthcaare
Lunan Pharmaceutical Group
Pfizer
Beijing Union Pharmaceutical Factory
Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
Chapter 1, to describe Epirubicin Hydrochloride product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Epirubicin Hydrochloride, with price, sales, revenue and global market share of Epirubicin Hydrochloride from 2018 to 2023.
Chapter 3, the Epirubicin Hydrochloride competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Epirubicin Hydrochloride breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2018 to 2029.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2018 to 2029.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2022.and Epirubicin Hydrochloride market forecast, by regions, type and application, with sales and revenue, from 2024 to 2029.
Chapter 12, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War.
Chapter 13, the key raw materials and key suppliers, and industry chain of Epirubicin Hydrochloride.
Chapter 14 and 15, to describe Epirubicin Hydrochloride sales channel, distributors, customers, research findings and conclusion.
According to our Researcher latest study, the global Epirubicin Hydrochloride market size was valued at USD 260.5 million in 2022 and is forecast to a readjusted size of USD 219.9 million by 2029 with a CAGR of -2.4% during review period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
Global core Epirubicin Hydrochloride players include Synbias Pharma, Zhejiang Hisun Pharma and Pfizer etc. The top 3 companies hold a share about 60%. Asia-Pacific is the largest market, with a share about 45%, followed by Europe and North America with the share about 25% and 20%.
In terms of product, 10mg/5ml is the largest segment, with a share about 45%, followed by 50mg/25ml, with a share about 40%. And in terms of application, the largest application is cancer, with a share about 95%, followed by others, with a share about 5%.
This report is a detailed and comprehensive analysis for global Epirubicin Hydrochloride market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.
Key Features:
Global Epirubicin Hydrochloride market size and forecasts, in consumption value ($ Million), sales quantity (Kg), and average selling prices (US$/Kg), 2018-2029
Global Epirubicin Hydrochloride market size and forecasts by region and country, in consumption value ($ Million), sales quantity (Kg), and average selling prices (US$/Kg), 2018-2029
Global Epirubicin Hydrochloride market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (Kg), and average selling prices (US$/Kg), 2018-2029
Global Epirubicin Hydrochloride market shares of main players, shipments in revenue ($ Million), sales quantity (Kg), and ASP (US$/Kg), 2018-2023
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Epirubicin Hydrochloride
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Epirubicin Hydrochloride market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Sterling Biotech, Zhejiang Hisun Pharma, Flavine, Teva API and Microbiopharm Japan, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Market Segmentation
Epirubicin Hydrochloride market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
10mg/5ml
50mg/25ml
Other
Market segment by Application
Cancer
Others
Major players
coveredSterling Biotech
Zhejiang Hisun Pharma
Flavine
Teva API
Microbiopharm Japan
DZD Heze Pharma
Synbias Pharma
Intas Pharma
Humble Healthcaare
Lunan Pharmaceutical Group
Pfizer
Beijing Union Pharmaceutical Factory
Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Epirubicin Hydrochloride product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Epirubicin Hydrochloride, with price, sales, revenue and global market share of Epirubicin Hydrochloride from 2018 to 2023.
Chapter 3, the Epirubicin Hydrochloride competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Epirubicin Hydrochloride breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2018 to 2029.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2018 to 2029.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2022.and Epirubicin Hydrochloride market forecast, by regions, type and application, with sales and revenue, from 2024 to 2029.
Chapter 12, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War.
Chapter 13, the key raw materials and key suppliers, and industry chain of Epirubicin Hydrochloride.
Chapter 14 and 15, to describe Epirubicin Hydrochloride sales channel, distributors, customers, research findings and conclusion.
Frequently Asked Questions
This market study covers the global and regional market with an
in-depth analysis of the
overall growth prospects...
- By product type
- By End User/Applications
- By Technology
- By Region
The report provides a detailed evaluation of the market by
highlighting information on
different aspects including drivers, restraints...
